市场调查报告书
商品编码
1622358
小动物影像市场规模、份额、成长分析、按模式、按应用、按试剂、按地区 - 产业预测,2025-2032Small Animal Imaging Market Size, Share, Growth Analysis, By Modality (Optical Imaging Systems, Nuclear Imaging), By Application (Monitoring Drug Treatment Response, Biodistribution Studies), By Reagent, By Region - Industry Forecast 2025-2032 |
2023年小动物影像市场规模为93.9亿美元,从2024年的99.9亿美元成长到2032年的164.4亿美元,预计复合年增长率为6.42%。
由于其在药物发现、疾病研究和生物过程阐明中的重要作用,全球小动物影像市场正在经历显着增长。该领域提供了对分子和细胞机制的重要见解,并促进了标靶治疗和个人化治疗策略的开发。製药和生物技术产业依靠临床前测试来评估候选药物的安全性和有效性,极大地推动了对这些技术的需求。高解析度显像模式和增强扫描功能等技术进步正在提高临床前评估的准确性和效率,进一步推动市场扩张。此外,多模态成像技术和混合系统的整合扩展了小动物成像的能力,允许更丰富、更准确的资料收集,这对于推进研究和治疗开发至关重要。
Small Animal Imaging Market size was valued at USD 9.39 Billion in 2023 and is poised to grow from USD 9.99 Billion in 2024 to USD 16.44 Billion by 2032, growing at a CAGR of 6.42% during the forecast period (2025-2032).
The global small animal imaging market is witnessing remarkable growth, driven by its vital role in drug discovery, disease research, and biological process understanding. This sector provides crucial insights into molecular and cellular mechanisms, facilitating the development of targeted therapies and personalized treatment strategies. The pharmaceutical and biotechnology industries significantly boost demand for these technologies, relying on preclinical studies to assess new drug candidates' safety and efficacy. Technological advancements, such as high-resolution imaging modalities and enhanced scanning capabilities, have further propelled market expansion, improving the accuracy and efficiency of preclinical assessments. Additionally, the integration of multimodal imaging techniques and hybrid systems has broadened small animal imaging's capabilities, allowing for richer and more precise data acquisition, crucial for advancing research and therapeutic development.
Top-down and bottom-up approaches were used to estimate and validate the size of the Small Animal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Small Animal Imaging Market Segmental Analysis
Global Small Animal Imaging Market is segmented by modality, application, reagent and region. Based on modality, the market is segmented into optical imaging systems, nuclear imaging and other imaging modalities. Based on application, the market is segmented into monitoring drug treatment response, biodistribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics. Based on reagents, the market is segmented into optical imaging reagents and nuclear imaging reagents. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Small Animal Imaging Market
The Small Animal Imaging market is primarily driven by the increasing focus on preclinical research within the pharmaceutical, biotechnology, and life sciences sectors. As the need for detailed investigations into diseases intensifies, the demand for sophisticated small animal imaging systems is on the rise. These cutting-edge imaging technologies provide researchers with the capability to perform comprehensive studies on various diseases, track their progression, assess the efficacy of treatments, and evaluate the safety and toxicity of novel drugs or therapies. This heightened emphasis on preclinical research is significantly contributing to the growth of the small animal imaging market.
Restraints in the Small Animal Imaging Market
The Small Animal Imaging market faces several constraints, notably the restricted availability of imaging agents. The process of developing and validating imaging agents specifically designed for preclinical studies can be both lengthy and expensive, which hinders their broader acceptance and use. This scarcity of suitable imaging agents can significantly affect the overall deployment of small animal imaging technologies within research environments, leading to potential delays in scientific progress and diminishing the effectiveness of preclinical studies. Consequently, this limitation may restrict researchers' ability to achieve comprehensive results, ultimately impacting the growth and application of the Small Animal Imaging market.
Market Trends of the Small Animal Imaging Market
The global small animal imaging market is witnessing a significant trend towards the increased adoption of multimodal imaging techniques, which integrate various imaging modalities to enhance the understanding of biological processes and disease progression in small animals. This trend is propelled by the demand for more precise and detailed imaging data in preclinical research and drug development. By utilizing a combination of techniques like positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging, researchers gain complementary insights that improve the sensitivity and specificity of imaging studies, ultimately fostering advancements in therapeutic efficacy and research outcomes.